Want to see HK:2389 full AI Analyst Report?
2389 Stock Chart & Stats
HK$0.06
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.06
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.06 - HK$0.09
Previous CloseN/A
Volume210.00K
Average Volume (3M)620.20K
Market Cap
HK$484.70M
Enterprise ValueHK$373.57
Total Cash (Recent Filing)HK$220.43M
Total Debt (Recent Filing)HK$31.70M
Price to Earnings (P/E)―
Beta0.07
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding6,058,772,000
10 Day Avg. Volume736,200
30 Day Avg. Volume620,200
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)0.23
Price to Sales (P/S)2.47
P/FCF Ratio-21.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low leverage reduces fixed financial obligations and preserves flexibility while the company works through operational weakness. A modest debt burden can limit refinancing pressure and leave more capacity to support essential investment or restructuring over the next several quarters.
Substantial Equity Asset BaseThe sizable equity base relative to total assets provides a meaningful capital cushion against business volatility. Although ongoing losses can erode it, this current balance-sheet position offers greater resilience and supports continuity than a highly leveraged structure would.
Revenue ReboundThe return to revenue growth in 2025 indicates that demand or business activity improved after the prior period. While the rebound is modest and not yet matched by profitability, renewed top-line traction could provide a base for operating improvement if sustained.
Bears Say
Persistent Large LossesDeep operating and net losses show that the current business model is not generating sufficient earnings from revenue. Continued losses can erode the equity base, restrict internal funding, and require management to make difficult decisions on costs, investment, or business structure.
Negative Cash GenerationNegative operating and free cash flow indicate that reported activity is not translating into self-funded liquidity. If this pattern persists alongside losses, the company may face greater funding pressure and reduced flexibility to maintain operations or invest in future growth.
Severe Margin CompressionThe sharp decline in gross margin weakens the economics of each unit of revenue and makes a return to profitability more difficult. Unless margins recover, even renewed sales growth may produce limited operating leverage and leave earnings vulnerable to further deterioration.
Beijing Health (Holdings) Limited News
2389 FAQ
What was Beijing Health (Holdings) Limited’s price range in the past 12 months?
Beijing Health (Holdings) Limited lowest stock price was HK$0.06 and its highest was HK$0.09 in the past 12 months.
What is Beijing Health (Holdings) Limited’s market cap?
Beijing Health (Holdings) Limited’s market cap is HK$484.70M.
When is Beijing Health (Holdings) Limited’s upcoming earnings report date?
Beijing Health (Holdings) Limited’s upcoming earnings report date is Apr 01, 2027 which is in 188 days.
How were Beijing Health (Holdings) Limited’s earnings last quarter?
Beijing Health (Holdings) Limited released its earnings results on Aug 31, 2026. The company reported -HK$0.005 earnings per share for the quarter.
Is Beijing Health (Holdings) Limited overvalued?
According to Wall Street analysts Beijing Health (Holdings) Limited’s price is currently Overvalued.
Does Beijing Health (Holdings) Limited pay dividends?
Beijing Health (Holdings) Limited does not currently pay dividends.
What is Beijing Health (Holdings) Limited’s EPS estimate?
Beijing Health (Holdings) Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beijing Health (Holdings) Limited have?
Beijing Health (Holdings) Limited has 6,058,772,000 shares outstanding.
What happened to Beijing Health (Holdings) Limited’s price movement after its last earnings report?
Beijing Health (Holdings) Limited reported an EPS of -HK$0.005 in its last earnings report. Following the earnings report the stock price went down -1.235%.
Which hedge fund is a major shareholder of Beijing Health (Holdings) Limited?
Currently, no hedge funds are holding shares in HK:2389
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beijing Health (Holdings) Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.81%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.68%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Beijing Health (Holdings) Limited
Beijing Health (Holdings) Limited, an investment holding company, provides medical, health, and geriatric care related services and products in the People’s Republic of China. It engages in the investment and operation of general health industrial park and incubator projects; sports businesses, which includes construction and operation of stadiums for winter sports; and investment in the field of the biotechnology, pharmaceutical, medical services, and medical travel. The company also provides investment management consulting services; and engages in trading geriatric care related furniture. In addition, it is involved in medical and logistics related property development activities. The company was formerly known as Beijing Enterprises Medical and Health Industry Group Limited and changed its name to Beijing Health (Holdings) Limited in June 2021. Beijing Health (Holdings) Limited was founded in 1995 and is headquartered in Cheung Sha Wan, Hong Kong.
Technical Analysis
Aidigong Maternal & Child Health
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―
UMP Healthcare Holdings Limited
―